Search

Besifloxacin

FDA approved on May 28, 2009.

Alirocumab

From this family, it was the first agent to receive FDA approval. The FDA approval was contingent on the completion of further clinical trials to better determine efficacy and safety. … Alirocumab is a biopharmaceutical that obtained FDA approval in July 2015 as a second line treatment for high cholesterol in adults whose LDL-cholesterol (LDL-C) is not controlled by the combination of

Racepinephrine

Epinephrine is a non-selective α- and β-adrenergic receptor agonist.

Potassium bicarbonate

[T141] It is registered in the FDA under the section of suitable, safe and effective ingredients for OTC antacids.[L1836] This FDA denomination classifies potassium bicarbonate as a GRAS ingredient.

Ferric carboxymaltose

It was FDA approved on July 25, 2013.

Atezolizumab

[L7489] Atezolizumab was granted FDA approval on 18 October 2016.

Chromous sulfate

Chromium gluconate

Chromium nicotinate

Imipramine

Imipramine may be used to treat depression and nocturnal enuresis in children [FDA Label].